Identification of a C/G polymorphism in the promoter region of the BRCA1 gene and its use as a marker for rapid detection of promoter deletions

British Journal of Cancer

Volumn 79, Issue 5-6, 1999, Pages 759-763

  Catteau, A ^a   Xu, C F ^a   Brown, M A ^a   Hodgson, S ^a   Greenman, J ^a   Mathew, C G ^a   Dunning, A M ^b   Solomon, E ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

BRCA1 promoter; Breast cancer; C G polymorphism; Deletion marker; Linkage disequilibrium

Indexed keywords

BRCA1 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; EXON; FAMILIAL CANCER; FEMALE; GENE DELETION; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION;

ADENOCARCINOMA; ADULT; AGE OF ONSET; BASE SEQUENCE; BREAST NEOPLASMS; CYTOSINE; DNA; DNA, NEOPLASM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; GENES, BRCA1; GENETIC MARKERS; GENOTYPE; GREAT BRITAIN; GUANINE; HUMANS; MALE; OVARIAN NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REFERENCE VALUES; SEQUENCE DELETION;

EID: 0033042481     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690122     Document Type: Article

References (24)

1. Ambrosone C, Freudenheim J, Marshall J, Graham S, Vena J, Brasure J, Michalek A, Laughlin R, Nemoto and Shields P (1995) The association of polymorphic N-acetyltransferase (NAT 2) with breast cancer risk. Ann New York Acad Sci 768: 250-252
2. Brown MA, Xu CF, Nicolai H, Griffiths B, Chambers JA, Black D and Solomon E (1996) The 5′ end of the BRCA1 gene lies within a duplicated region of human-chromosome 17q21. Oncogene 12: 2507-2513
3. Catteau A, Harris WH, Xu CF and Solomon E (1999) Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene
4. Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD and Kazazian HH (1984) Nonuniform recombination within the human β-globin gene cluster. Am J Hum Genet 36: 1239-1258
5. Couch FJ, Weber BL, Borresen AL, Brody L, Casey G, Devilee P, Fitzgerald M, Friend S, Gayther S, Goldgar D, Murphy P, Szabo C, Weber B, Wiseman R, Anderson T, Durocher F, Ganguly A, King MC, Lenoir G, Narod S, Olopade O, Plummer S, Ponder B, Serova O, Simard J, Stratton M and Warren B (1996) Mutations and polymorphisms in the familial early-onset breast-cancer (BRCA1) gene. Hum Mutat 8: 8-18
6. Dobrovic A and Simpfendorfer D (1997) Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57: 3347-3350
7. Dunning AM, Chiano M, Smith NR, Dearden J, Gore M, Oakes S, Wilson C, Stratton M, Peto J, Easton D, Clayton D and Ponder BAJ (1997) Common BRCA1 variants and susceptibility to breast and ovarian-cancer in the general population. Hum Mol Genet 6: 285-289
8. Feigelson HS, Coetzee GA, Kolonel LN, Ross RK and Henderson BE (1997) A polymorphism in the CYP17 Gene increases the risk of breast cancer. Cancer Res 57: 1063-1065
9. Ford D, Easton DF and Peto J (1995) Estimates of the gene-frequency of BRCA1 and its contribution to breast and ovarian-cancer incidence. Am J Hum Genet 57: 1457-1462
10. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart JD, Marks J, Ballinger DG, Barrett JC, Skolnick MH, Kamb A and Wiseman R (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122
11. Hosking L, Trowsdale J, Nicolai H, Solomon E, Foulkes W, Stamp G, Signer E and Jeffreys A (1995) A somatic BRCA1 mutation in an ovarian tumor. Nature Genet 9: 343-344
12. Krontiris TG, Devlin DB, Karp DD, Robert NJ and Risch N (1993) An association between the risk of cancer and mutations in HRAS1 minisatellite locus. New Engl J Med 329: 517-523
13. Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W and Archer TK (1998) CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site Oncogene 16: 1161-1169
14. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C and Frank TS (1995) Somatic mutations in the Brca1 gene in sporadic ovarian-tumors. Nature Genet 9: 439-443
15. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennet LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Sone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71
16. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC and Markham AF (1989) Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acios Res 17: 1503-1516
17. Petrij-Bosch A, Peelen T, Van Vliet M, Van Eijk R, Olmer R, Drusedau M, Hogervorst FBL, Hageman S, Arts PJW, Ligtenberg MJL, Meijers-Heijboer H, Klijn JGM, Vasen HFA, Cornelisse CJ, Van't Veer LJ, Bakker E, Van Ommen G-JB and Devilee P (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nature Genet 17: 341-345
18. Puget N, Torchard D, Serovasinilnikova OM, Lynch HT, Feunteun J, Lenoir GM and Mazoyer S (1997) A 1-kb alu-mediated germ-line deletion removing BRCA1 exon-17. Cancer Res 57: 828-831
19. Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, Hood L and King MC (1996) Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 6: 1029-1049
20. Swensen J, Hohhman M, Skolnick MH and Neuhausen SL (1997) Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum Mol Genet 6: 1513-1517
21. Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast-cancer progression. Nature Genet 9: 444-450
22. Xu C-F, Brown MA, Chambers JA, Griffiths B, Nicolai H and Solomon E (1995) Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum Mol Genet 4: 2259-2264
23. Xu C-F and Solomon E (1996) Mutations of the BRCA1 gene in human cancer. Semin Cancer Biol 7: 33-40
24. Xu C-F, Chambers JA and Solomon E (1997) Complex regulation of the BRCA1 gene. J Biol Chem 272: 20994-20997